Search results
1 – 6 of 6Peripheral arterial disease (PAD) is an occlusive atherosclerotic disease that affects blood vessels and reduces blood flow in the lower limbs. It is estimated that around 200…
Abstract
Peripheral arterial disease (PAD) is an occlusive atherosclerotic disease that affects blood vessels and reduces blood flow in the lower limbs. It is estimated that around 200 million people worldwide suffered from it, with a significant number of older people affected. Walking is one of the first-line therapeutic measures for intermittent claudication (IC) in patients with PAD. Supervised Exercise Therapy (SET) programs effectively increase walking distances, however, remain an underutilized tool because they are not readily available in most clinical centres, are extremely expensive, and patient participation is low mainly due to socioeconomic constraints. Home-based Exercise Therapy (HBET) programs are an effective and low-cost alternative to improve both the functional capacity and quality of life (QoL) of patients with IC, as they are performed in the patient’s area of residence and not in the hospital. The WalkingPad program conciliated a smartphone app – the WalkingPad app – with behaviour change intervention to increase walking distances and decrease walking impairment as well to improve QoL at 6 months.
Details
Keywords
This chapter provides a review of the literature relating to intellectual capital and firm performance in the context of corporate reputation. Section 2.2 outlines the definitions…
Abstract
This chapter provides a review of the literature relating to intellectual capital and firm performance in the context of corporate reputation. Section 2.2 outlines the definitions of intellectual capital and how they differ from the definitions offered for intangibles by accounting regulators. Section 2.3 reviews the categorisation of intellectual capital and looks at two major models of categorisation. Section 2.4 examines the definition of intellectual capital disclosure. Section 2.5 examines firm performance from the viewpoint of firm reputation for value-relevant disclosure. Section 2.6 discusses firm reputation in the context of intellectual capital disclosure. Section 2.7 provides a summary of the chapter.